SM

Steven M

Mutual Connections
Loading...
S9-052025-1213927

Send Message

No file chosen
1 Publications
0 Followers
0 Following
0 Questions

👤 About

Skills & Expertise

No skills added yet.

Research Interests

No research interests added yet.

Connect With Me

📚 Publications (1)

Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma
Journal: Leukemia & Lymphoma • February 2025
In this phase-2a study (NCT01994382), patients aged ≥18 years with relapsed/refractory peripheral T-cell lymphoma (PTCL; angioimmunoblastic T-cell lymphoma/T follicular helper [AITL/TFH], n = 29); PTC...
Phase-2 study Peripheral t-cell lymphoma Dual spleen tyrosine kinase/janus kinase inhibitor Relapsed/refractory
dd